Publication:
Effective Tetradentate Compound Complexes against Leishmania spp. that Act on Critical Enzymatic Pathways of These Parasites.

dc.contributor.authorUrbanová, Kristína
dc.contributor.authorRamírez-Macías, Inmaculada
dc.contributor.authorMartín-Escolano, Rubén
dc.contributor.authorRosales, María José
dc.contributor.authorCussó, Olaf
dc.contributor.authorSerrano, Joan
dc.contributor.authorCompany, Anna
dc.contributor.authorSánchez-Moreno, Manuel
dc.contributor.authorCostas, Miquel
dc.contributor.authorRibas, Xavi
dc.contributor.authorMarín, Clotilde
dc.date.accessioned2023-01-25T10:27:17Z
dc.date.available2023-01-25T10:27:17Z
dc.date.issued2018-12-31
dc.description.abstractThe spectrum and efficacy of available antileishmanial drugs is limited. In the present work we evaluated in vitro the antiproliferative activity of 11 compounds based on tetradentate polyamines compounds against three Leishmania species (L. braziliensis, L. donovani and L. infantum) and the possible mechanism of action. We identified six compounds (3, 5, 6, 7, 8 and 10) effective against all three Leishmania spp both on extracellular and intracellular forms. These six most active leishmanicidal compounds also prevent the infection of host cells. Nevertheless, only compound 7 is targeted against the Leishmania SOD. Meanwhile, on the glucose metabolism the tested compounds have a species-specific effect on Leishmania spp.: L. braziliensis was affected mainly by 10 and 8, L. donovani by 7, and L. infantum by 5 and 3. Finally, the cellular ultrastructure was mainly damaged by 11 in the three Leishmania spp. studied. These identified antileishmania candidates constitute a good alternative treatment and will be further studied.
dc.identifier.doi10.3390/molecules24010134
dc.identifier.essn1420-3049
dc.identifier.pmcPMC6337631
dc.identifier.pmid30602705
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337631/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1420-3049/24/1/134/pdf?version=1546256897
dc.identifier.urihttp://hdl.handle.net/10668/13370
dc.issue.number1
dc.journal.titleMolecules (Basel, Switzerland)
dc.journal.titleabbreviationMolecules
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectLeishmania spp.
dc.subjectSOD
dc.subjectamastigote
dc.subjectantileishmania
dc.subjectantiproliferative
dc.subjectpromastigote
dc.subjecttetradentate polyaminic compounds
dc.subjectultrastructure
dc.subject.meshAnimals
dc.subject.meshAntiprotozoal Agents
dc.subject.meshCell Line
dc.subject.meshGene Expression Regulation, Enzymologic
dc.subject.meshLeishmania
dc.subject.meshMacrophages
dc.subject.meshMice
dc.subject.meshMicroscopy, Electron, Transmission
dc.subject.meshMolecular Structure
dc.subject.meshParasitic Sensitivity Tests
dc.subject.meshPolyamines
dc.subject.meshProtozoan Proteins
dc.subject.meshSuperoxide Dismutase
dc.titleEffective Tetradentate Compound Complexes against Leishmania spp. that Act on Critical Enzymatic Pathways of These Parasites.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number24
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6337631.pdf
Size:
5.98 MB
Format:
Adobe Portable Document Format